CJM-112

N/A

Report date: 2026/03/17 20:00:15

Base Information

Drug NameCJM-112
Drug Alias NameCJM-112
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin 17A inhibitors
TargetsInterleukin 17A
Therapy Area/IndicationsPlaque psoriasisPsoriasisAcne Vulgaris +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgChina Novartis Institutes For Biomedical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisMultiple SclerosisHidradenitis Suppurativa
Inactive IndicationsPlaque psoriasisAcne VulgarisAcneiform Eruptions +[9] 

Other Information

ATC CodeN/A
Related LinksN/A